Exane Derivatives’s Lamb Weston LW Stock Holding History

Exane Derivatives’s Portfolio LW Stock Details LW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-179	Closed	-$8.39K	–	626
2017 Q3	$8.39K	Hold	179	–	–	﹤0.01%	407
2017 Q2	$7.88K	Hold	179	–	–	﹤0.01%	414
2017 Q1	$7.53K	Hold	179	–	–	﹤0.01%	364
2016 Q4	$6.77K	Buy	+179	New	+$6.1K	﹤0.01%	424

Other funds holding LW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NCA

Newbrook Capital Advisors New York $560M AUM 62.9% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Exane Derivatives's LW Position: Q4 2017 in Review

Exane Derivatives sold out of Lamb Weston (LW) in Q4 2017, closing a stake of 179 shares — an estimated $8.39K sold.

Exane Derivatives first reported a position in LW in Q4 2016 and held it in 4 quarters. The position peaked at $8.39K in Q3 2017. 506 funds tracked by Wall St. Rank hold LW as of Q4 2017.

Exane Derivatives reported no remaining Lamb Weston position as of Q4 2017 after selling out during the quarter.
Exane Derivatives sold 179 Lamb Weston shares in Q4 2017, an estimated $8.39K.
Exane Derivatives first reported a position in Lamb Weston in Q4 2016 and held it in 4 quarters.
Exane Derivatives's Lamb Weston position peaked at $8.39K in Q3 2017.
506 funds tracked by Wall St. Rank held Lamb Weston as of Q4 2017.

Based on Exane Derivatives's 13F filing for Q4 2017, filed 29 Jan 2018.